Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE).

<h4>Objective</h4>To evaluate treatment satisfaction, disease outcomes, and perspectives of patients with poorly controlled rheumatoid arthritis (RA) treated with conventional synthetic, targeted synthetic, or biologic disease-modifying antirheumatic drugs (DMARDs), we conducted a subgro...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yutaka Kawahito, Yuya Takakubo, Akio Morinobu, Naoko Matsubara, Orsolya Nagy, Eiji Sugiyama
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/5ee941d736cb4095afc84d1a0dee0c93
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5ee941d736cb4095afc84d1a0dee0c93
record_format	dspace
spelling	oai:doaj.org-article:5ee941d736cb4095afc84d1a0dee0c932021-12-02T20:13:09ZPatient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE).1932-620310.1371/journal.pone.0259389https://doaj.org/article/5ee941d736cb4095afc84d1a0dee0c932021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0259389https://doaj.org/toc/1932-6203<h4>Objective</h4>To evaluate treatment satisfaction, disease outcomes, and perspectives of patients with poorly controlled rheumatoid arthritis (RA) treated with conventional synthetic, targeted synthetic, or biologic disease-modifying antirheumatic drugs (DMARDs), we conducted a subgroup (post hoc) analysis of Japanese patients participating in the SENSE study.<h4>Methods</h4>Data for Japanese patients (n/N = 118/1629) from the global, multicenter, cross-sectional, observational SENSE study were analyzed. The primary endpoint was the global satisfaction subscore assessed using the Treatment Satisfaction Questionnaire for Medication (TSQM) version 1.4. Other patient-reported outcomes included self-reported RA medication adherence and Work Productivity and Activity Impairment-RA. Patient perspectives included patients' expectations and preference of pharmacologic treatment.<h4>Results</h4>Median (range) age and RA disease duration were 67.0 (18.0-87.0) years and 8 (0.0-54) years, respectively; 81.4% of patients were female. Mean (SD) TSQM global satisfaction subscore was 56.8 (17.5), and only 5.9% of patients reported good satisfaction with treatment (TSQM global ≥80). Mean (SD) self-reported treatment adherence using VAS was high (93.5% [13.8%]). Mean (SD) total work productivity impairment was 45.6% (32.0%); presenteeism contributed toward more total work productivity impairment (43.9% [30.4%]) than absenteeism (8.3% [24.4%]). Patients expected improvement in all parameters from their treatment, especially improvement in joint symptoms. Most patients (80.7%) preferred oral medication and 18.7% preferred monotherapy. Patient acceptability of potentially manageable side effects was high (7.5%-34.0%). Although most patients (81.3%) found combination therapy acceptable, 43.2% were receiving DMARD monotherapy.<h4>Conclusion</h4>Although most Japanese patients with RA with moderate-to-high disease activity were dissatisfied with their current DMARD treatment, high treatment adherence, high acceptability of combination therapy, high acceptability of manageable potential side effects, and preference for oral medication were reported. Data support the development of a more individualized and patient-centric approach for RA treatment.Yutaka KawahitoYuya TakakuboAkio MorinobuNaoko MatsubaraOrsolya NagyEiji SugiyamaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 11, p e0259389 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Yutaka Kawahito Yuya Takakubo Akio Morinobu Naoko Matsubara Orsolya Nagy Eiji Sugiyama Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE).
description	<h4>Objective</h4>To evaluate treatment satisfaction, disease outcomes, and perspectives of patients with poorly controlled rheumatoid arthritis (RA) treated with conventional synthetic, targeted synthetic, or biologic disease-modifying antirheumatic drugs (DMARDs), we conducted a subgroup (post hoc) analysis of Japanese patients participating in the SENSE study.<h4>Methods</h4>Data for Japanese patients (n/N = 118/1629) from the global, multicenter, cross-sectional, observational SENSE study were analyzed. The primary endpoint was the global satisfaction subscore assessed using the Treatment Satisfaction Questionnaire for Medication (TSQM) version 1.4. Other patient-reported outcomes included self-reported RA medication adherence and Work Productivity and Activity Impairment-RA. Patient perspectives included patients' expectations and preference of pharmacologic treatment.<h4>Results</h4>Median (range) age and RA disease duration were 67.0 (18.0-87.0) years and 8 (0.0-54) years, respectively; 81.4% of patients were female. Mean (SD) TSQM global satisfaction subscore was 56.8 (17.5), and only 5.9% of patients reported good satisfaction with treatment (TSQM global ≥80). Mean (SD) self-reported treatment adherence using VAS was high (93.5% [13.8%]). Mean (SD) total work productivity impairment was 45.6% (32.0%); presenteeism contributed toward more total work productivity impairment (43.9% [30.4%]) than absenteeism (8.3% [24.4%]). Patients expected improvement in all parameters from their treatment, especially improvement in joint symptoms. Most patients (80.7%) preferred oral medication and 18.7% preferred monotherapy. Patient acceptability of potentially manageable side effects was high (7.5%-34.0%). Although most patients (81.3%) found combination therapy acceptable, 43.2% were receiving DMARD monotherapy.<h4>Conclusion</h4>Although most Japanese patients with RA with moderate-to-high disease activity were dissatisfied with their current DMARD treatment, high treatment adherence, high acceptability of combination therapy, high acceptability of manageable potential side effects, and preference for oral medication were reported. Data support the development of a more individualized and patient-centric approach for RA treatment.
format	article
author	Yutaka Kawahito Yuya Takakubo Akio Morinobu Naoko Matsubara Orsolya Nagy Eiji Sugiyama
author_facet	Yutaka Kawahito Yuya Takakubo Akio Morinobu Naoko Matsubara Orsolya Nagy Eiji Sugiyama
author_sort	Yutaka Kawahito
title	Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE).
title_short	Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE).
title_full	Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE).
title_fullStr	Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE).
title_full_unstemmed	Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE).
title_sort	patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: a subgroup analysis of japanese patients from a large international cohort study (sense).
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/5ee941d736cb4095afc84d1a0dee0c93
work_keys_str_mv	AT yutakakawahito patientsatisfactionpreferencesexpectationscharacteristicsandimpactofsuboptimalcontrolofrheumatoidarthritisasubgroupanalysisofjapanesepatientsfromalargeinternationalcohortstudysense AT yuyatakakubo patientsatisfactionpreferencesexpectationscharacteristicsandimpactofsuboptimalcontrolofrheumatoidarthritisasubgroupanalysisofjapanesepatientsfromalargeinternationalcohortstudysense AT akiomorinobu patientsatisfactionpreferencesexpectationscharacteristicsandimpactofsuboptimalcontrolofrheumatoidarthritisasubgroupanalysisofjapanesepatientsfromalargeinternationalcohortstudysense AT naokomatsubara patientsatisfactionpreferencesexpectationscharacteristicsandimpactofsuboptimalcontrolofrheumatoidarthritisasubgroupanalysisofjapanesepatientsfromalargeinternationalcohortstudysense AT orsolyanagy patientsatisfactionpreferencesexpectationscharacteristicsandimpactofsuboptimalcontrolofrheumatoidarthritisasubgroupanalysisofjapanesepatientsfromalargeinternationalcohortstudysense AT eijisugiyama patientsatisfactionpreferencesexpectationscharacteristicsandimpactofsuboptimalcontrolofrheumatoidarthritisasubgroupanalysisofjapanesepatientsfromalargeinternationalcohortstudysense
_version_	1718374824893480960

Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE).

Ejemplares similares